Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.54 |
| ▸ | C1R | P00736 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.40 |
| ▸ | F3 | P13726 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | KIF20B | Q96Q89 | 1/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | IGF1R | P08069 | 1/20 | 0.37 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | MARK3 | P27448 | 1/20 | 0.37 |
| ▸ | KDR | P35968 | 1/20 | 0.37 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.37 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9493411 | 0.90 | NT5E (0.51) | NT5EC1RKDM4EPARP1LMNA | |
| SCHEMBL9493259 | 0.90 | C1R (0.50) | NT5EC1RKDM4EPARP1LMNA | |
| SCHEMBL2709353 | 0.86 | NT5E (0.68) | NT5EKDM4ELMNABACE1PDE2A | |
| SCHEMBL31327779 | 0.86 | NT5E (0.68) | NT5EKDM4ELMNABACE1PDE2A | |
| SCHEMBL23066252 | 0.86 | C1R (0.46) | NT5EC1RKDM4EPARP1LMNA | |
| SCHEMBL8396844 | 0.84 | C1R (0.45) | NT5EC1RKDM4EPARP1LMNA | |
| SCHEMBL3344697 | 0.84 | NT5E (0.56) | NT5EKDM4ELMNAIGF1RGSK3A | |
| SCHEMBL900362 | 0.83 | MAPT (0.51) | C1RKDM4EPARP1LMNAF7 | |
| SCHEMBL3850835 | 0.81 | BACE1 (0.45) | NT5EKDM4EPARP1LMNAF7 | |
| SCHEMBL3828474 | 0.81 | BACE1 (0.45) | NT5EKDM4EPARP1LMNAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017136642-A1 | ANTIBIOTIC COMPOSITIONS | THE TRUSTEES OF DARTMOUTH COLLEGE (US) | 2017-08-10 | — | — | WO | disclosed |
| EP-1567477-B1 | SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS | NOVARTIS AG (CH) | 2009-09-09 | — | — | EP | disclosed |
| EP-2090566-A2 | Certain phenylacetic acids and derivatives | Novartis AG (CH) | 2009-08-19 | — | — | EP | disclosed |
| US-7202364-B2 | Certain phenylacetic acids and derivatives | NOVARTIS, AG (CH) | 2007-04-10 | — | — | US | disclosed |
| EP-1567477-A1 | SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS | Novartis AG (CH) | 2005-08-31 | — | — | EP | disclosed |
| US-20040132769-A1 | Certain phenylacetic acids and derivatives | NOVARTIS AG (CH) | 2004-07-08 | — | — | US | disclosed |
| WO-2004048314-A1 | SUBSTITUTED AMINO PHENYLACETIC ACIDS, DERIVATIVES THEREOF, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS | NOVARTIS AG (CH) | 2004-06-10 | — | — | WO | disclosed |
| EP-0111329-B1 | FLUOROMETHYL QUINOLINE DERIVATIVES AND THEIR PREPARATION | ALKALOIDA VEGYESZETI GYAR (HU) | 1989-03-15 | — | — | EP | disclosed |
| US-4659834-A | Process for the preparation of fluoromethyl-quinoline derivatives | ALKALOIDA VEGYESZETI GYAR (HU) | 1987-04-21 | — | — | US | disclosed |
| EP-0111329-A1 | Fluoromethyl quinoline derivatives and their preparation | ALKALOIDA VEGYESZETI GYAR (HU) | 1984-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132769-A1 | Certain phenylacetic acids and derivatives | CYP2A6, HCAR2, CYP2B6 | NT5E 3158/4885C1R 1521/4885KDM4E 3616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.